Diabetes treatment lowers PromarkerD risk score: Results presented at Australasian Diabetes Congress
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) is pleased to...
Related posts
Latest PromarkerD clinical validation results published in the Journal of Diabetes and its...
Clinical validation results confirm PromarkerD can predict diabetic kidney disease better than any...